The proposed field trial will clarify the real-world effectiveness of HAs in remediating deficits in emotion processing for older adults with mild-to-moderate hearing loss. This study will employ a repeated reversal design to establish baseline affective state without HAs, when wearing amplification, and after HAs are removed. This study will triangulate self-report, behavioral, and physiological measures to capture nuances of emotional processing in the laboratory and in daily listening. Naturalistic stimuli will be used as it occurs in daily life to elicit emotional experiences, and ecological momentary assessment and commercially-available wearable sensors will be used to track changes in emotional state in daily listening. Anchoring real-world emotional experiences with controlled laboratory experiences will validate wearable sensors. Additionally, laboratory emotional stimuli will be related to real-world emotional experiences to establish the utility of laboratory stimuli in future studies. It is likely that benefits in emotional processing will have differential effects based on individual characteristics (such as degree of hearing loss, age, gender, cognitive ability, and personality), so participants will be analyzed according to larger groupings based on individual differences.
Thirty-five participants will complete preliminary measures, including assessments of routine audiometrics, demographics, personality, and working memory. For each arm of the trial (baseline-unaided; aided; follow-up unaided) participants will be issued sensors to use while pursuing normal daily life activities. These sensors can provide information such as heart rate (HR) and respiration activity, which have been associated with the arousal dimension of emotion. Participants also will download a mobile app that will automatically prompt them throughout their day to indicate their perceived arousal and valence and listening-related workload. For each arm of the trial interindividual and intraindividual emotion perception, speech understanding, and perceived workload will be also be assessed using laboratory-based self-report, behavioral, and physiological measures. Subjective measures of hearing aid benefit, emotional consequences of hearing loss, and the effect of hearing loss on emotional communication will be assessed through validated questionnaires at the conclusion of each arm of the trial.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
35
Three week trial while wearing bilateral hearing devices.
University of Memphis
Memphis, Tennessee, United States
Self-reported arousal
Arousal rating measured with the Self-assessment manikin (SAM)
Time frame: Measured several times per day for 6 days in each arm of the study (ecological momentary assessment); and at a lab appointment on day 7; day 28; and day 35 of the trial.
Self-reported valence
Valence rating measured with the Self-assessment manikin (SAM)
Time frame: Measured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.
Self-reported task-load
Task-load rating measured with the NASA-TLX
Time frame: Measured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.
Physiological arousal - heart rate
Heartbeats per minute
Time frame: easured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.
Physiological arousal - respiration activity
Breaths per minute
Time frame: easured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.
Physiological arousal - electrodermal responses
Skin conductance in response to emotionally evocative sounds (International Affective Digital Sounds) at soft, average, loud levels
Time frame: Day 7; day 28; and day 35 of the trial.
Physiological valence - electromyography
Facial sEMG in response to emotionally evocative sounds (International Affective Digital Sounds) at soft, average, loud levels
Time frame: Day 7; day 28; and day 35 of the trial.
Emotion identification - Toronto Emotional Speech Set
Percent correct identification of emotion contained in auditory stimuli at soft, average, loud levels
Time frame: Day 7; day 28; and day 35 of the trial.
Word recognition - Toronto Emotional Speech Set
Percent correctly identified single word auditory stimuli at soft, average, loud levels
Time frame: Day 7; day 28; and day 35 of the trial.
Abbreviated Profile of Hearing Aid Benefit (APHAB)
Validated questionnaire that assesses frequency of problems with speech communication and aversiveness of sounds in daily listening
Time frame: Day 7; day 28; and day 35 of the trial.
Hearing Handicap Inventory for Elderly-Screening version (HHIE-S)
Validated questionnaire that measures the effects of hearing impairment on emotional and social adjustment
Time frame: Day 7; day 28; and day 35 of the trial.
Emotional Communication in Hearing Questionnaire (EMO-CHeQ)
Validated questionnaire that assesses benefits of hearing aids in addressing emotional communication.
Time frame: Day 7; day 28; and day 35 of the trial.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.